![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
If it were possible to watch drugs molecules at work under a microscope — seeing precisely how they act on different proteins inside cells — it would revolutionize drug development. Micrographia is doing just that. The company uses machine learning to analyze microscopy images at high throughput, allowing researchers and drug developers to unravel disease mechanisms at the subcellular level.
Using AI to speed through the last mile of drug discovery
Finding precisely tuned viral vectors for gene therapy in CNS disorders
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing